Once- versus twice-daily abacavir and lamivudine in African children: the randomised controlled ARROW Trial by Musiime, V, Kasirye, P, Naidoo-James, B, Nahirya-Ntege, P, Mhute, T, Cook, A, Mugarura, L, Munjoma, M, Thoofer, N, Ndashimye, E, Nankya, I, Spyer, M, Thomason, M, Snowden, W, Gibb, D, Walker, A, ARROW Trial Team

Routine versus clinically driven laboratory monitoring and first-line antiretroviral therapy strategies in African children with HIV (ARROW): a 5-year open-label randomised factori... by Kekitiinwa, A, Cook, A, Nathoo, K, Mugyenyi, P, Nahirya-Ntege, P, Bakeera-Kitaka, S, Thomason, M, Bwakura-Dangarembizi, M, Musiime, V, Munderi, P, Naidoo-James, B, Vhembo, T, Tumusiime, C, Katuramu, R, Crawley, J, Prendergast, A, Musoke, P, Walker, A, Gibb, D